Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT

Am J Hematol. 2024 May;99(5):993-996. doi: 10.1002/ajh.27262. Epub 2024 Feb 22.

Abstract

Investigating the evaluation of eligibility for transplant in myelofibrosis (MF): The role of HCT-CI and BMI. HCT-CI emerges as a key prognostic factor, while BMI shows limited impact. This study expands insights for better clinical decision-making in MF allo-HCT.

Publication types

  • Letter

MeSH terms

  • Body Mass Index
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Neoplasms*
  • Primary Myelofibrosis* / therapy
  • Retrospective Studies
  • Transplantation Conditioning